>Mercado de química medicinal para el descubrimiento de fármacos en América del Norte, por proceso ( selección de objetivos , validación de objetivos, identificación de hit-to-lead, optimización de leads y validación de candidatos), diseño (variación basada en fragmentos, diseño de fármacos basado en la estructura, síntesis orientada a la diversidad, quimiogenómica, productos naturales y otros), tipo de fármaco (moléculas pequeñas y productos biológicos), área terapéutica ( oncología , neurología, enfermedades infecciosas y del sistema inmunológico , enfermedades cardiovasculares, enfermedades del sistema digestivo y otras), usuario final (organización de investigación por contrato, empresas farmacéuticas y de biotecnología , institutos académicos y de investigación y otros), país (EE. UU., Canadá, México) Tendencias de la industria y pronóstico hasta 2029.
Análisis y perspectivas del mercado : mercado de química medicinal para el descubrimiento de fármacos en América del Norte
Se espera que el mercado de química medicinal para el descubrimiento de fármacos de América del Norte gane crecimiento de mercado en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 14,0% en el período de pronóstico de 2022 a 2029 y se espera que alcance los USD 6.768,27 millones para 2029. La creciente demanda de medicamentos especializados y el aumento de las enfermedades relacionadas con el estilo de vida son los principales impulsores que impulsaron la demanda del mercado en el período de pronóstico.
La química medicinal para el descubrimiento de fármacos comprende características tales como la creciente necesidad de fármacos seguros y eficaces que repercutirán en el lanzamiento de nuevos productos por parte de los fabricantes al mercado, lo que aumentará su demanda, así como el aumento de la inversión en investigación y desarrollo para el descubrimiento y desarrollo de nuevas moléculas de fármacos que conducen al crecimiento del mercado. Actualmente se están llevando a cabo varios estudios de investigación que se espera que brinden varias otras oportunidades en el mercado de la química medicinal para el descubrimiento de fármacos. Sin embargo, se espera que el aumento del costo de los fármacos formulados y las estrictas regulaciones limiten el crecimiento del mercado en el período de pronóstico.
El informe de mercado de química medicinal para el descubrimiento de fármacos proporciona detalles de la participación de mercado, nuevos desarrollos y análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de bolsas de ingresos emergentes, cambios en las regulaciones del mercado , aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, contáctenos para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado mundial de la química medicinal para el descubrimiento de fármacos
Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of process, the North America medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the market as it enhances the efficiency and effectiveness of the research and development process.
- On the basis of design, the North America medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug design, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the market as it is widely used in biotech, pharma and academic institutions to identify large number of compounds under clinical trials and drugs necessitate to launch.
- On the basis of drug type, the North America medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market as these molecules exhibits higher specificity, potency and long duration of action.
- On the basis of therapeutic area, the North America medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalence of cancer and increase in research and development for discovery of advanced therapeutic molecule.
- On the basis of end user, the North America medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the market due to increasing number of CROs and increasing investment in pharmaceutical research and development to drive the CROs services.
Medicinal Chemistry for Drug Discovery Market Country Level Analysis
The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.
The countries covered in the medicinal chemistry for drug discovery market report are the U.S., Canada, and Mexico.
The U.S. is leading in the North America medicinal chemistry in drug discovery market due to increasing initiatives for research on rare diseases and orphan drugs and rising healthcare expenses. Canada is growing in North America medicinal chemistry in drug discovery market due to increasing clinical trial and research & Development for various chronic disease. Mexico is growing in North America medicinal chemistry in drug discovery market due to the increasing awareness towards developing treatment for chronic disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Advancements in Technology and Increase in Initiatives for Research on Rare and Orphan Drugs are boosting the Market Growth of Medicinal Chemistry for Drug Discovery
Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2020.
Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis
Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.
Algunas de las principales empresas que se dedican al mercado de la química medicinal para el descubrimiento de fármacos son Eurofins Scientific, Covance Inc. (ahora parte del Grupo LabCorp), WuXi Apptec, Charles River, Evotec SE, Piramal Pharma Solutions, Pfizer, Inc., Certara, USA, Sygnature Discovery Limited, Malvern Panalytical Ltd (empresa matriz Spectris PLC), Jubilant Biosys Ltd. (una empresa limitada de Jubilant Pharmova), Taros Chemicals GmbH & Co. KG, Genscript Biotech Corporation, Nereid Therapeutics Inc., BioBlocks, Inc., Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services Ltd. (una subsidiaria de Dr. Reddy's Laboratories Ltd.), Selvita, Nanosyn, Drug Discovery Alliances Inc., entre otras.
Varios actores del mercado proporcionan las últimas tecnologías de química medicinal para el descubrimiento de fármacos, lo que también está acelerando el mercado de la química medicinal para el descubrimiento de fármacos.
Por ejemplo,
- En febrero de 2021, Selvita lanzó su nueva plataforma de análisis fenotípico basado en células para el descubrimiento de fármacos. La plataforma lanzada se utiliza para probar nuevos compuestos con potencial terapéutico en el tratamiento de múltiples enfermedades, incluidas enfermedades fibróticas y enfermedades neuroinflamatorias, entre otras. La plataforma lanzada permitió a la empresa generar más ingresos a partir de su cartera de servicios de descubrimiento de fármacos.
- En agosto de 2020, Piramal Pharma Solutions colaboró con Epirium Bio en un programa exclusivo de desarrollo y fabricación integrados de medicamentos huérfanos. Este programa de integración abarca el desarrollo de fórmulas, las sustancias farmacológicas y la fabricación de productos farmacéuticos. Esta colaboración mejoró la cartera existente de la empresa en química medicinal para el descubrimiento de fármacos.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en la química medicinal para el descubrimiento de fármacos, lo que también proporciona el beneficio para que la organización mejore su oferta para la bronquiectasia.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PROCESS LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 POTERS FIVE FORCES
5 NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN R&D FOR DISCOVERY AND DEVELOPMENT OF NOVEL DRUG MOLECULES
6.1.2 RISE IN CHRONIC DISEASES
6.1.3 INITIATIVES FOR RESEARCH ON RARE DISEASES AND ORPHAN DRUGS
6.1.4 GROWTH IN BIOLOGICS
6.1.5 COLLABORATIONS AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRIES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF FORMULATED DRUG
6.2.2 TECHNICAL RISKS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.2.3 BIOETHICAL ISSUES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN BIOCHEMICAL, TRANSLATIONAL, AND MOLECULAR STUDIES
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 USE OF ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.4 CHALLENGES
6.4.1 BIOLOGICS NEED SPECIALIST TESTING SERVICES
6.4.2 STRINGENT REGULATIONS
7 IMPACT OF COVID-19 ON NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS BY MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS
8.1 OVERVIEW
8.2 TARGET SELECTION
8.3 TARGET VALIDATION
8.4 HIT-TO-LEAD IDENTIFICATION
8.5 LEAD OPTIMIZATION
8.6 CANDIDATE VALIDATION
9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN
9.1 OVERVIEW
9.2 FRAGMENT-BASED VARIATION
9.3 STRUCTURE BASED DRUG DESIGN
9.4 DIVERSITY ORIENTED SYNTHESIS
9.5 CHEMOGENOMICS
9.6 NATURAL PRODUCTS
9.7 OTHERS
10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 SMALL MOLECULES
10.3 BIOLOGICS
11 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 NEUROLOGY
11.4 INFECTIOUS AND IMMUNE SYSTEM DISEASES
11.5 CARDIOVASCULAR DISEASES
11.6 DIGESTIVE SYSTEM DISEASES
11.7 OTHERS
12 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER
12.1 OVERVIEW
12.2 CONTRACT RESEARCH ORGANIZATION
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 ACADEMIC AND RESEARCH INSTITUTES
12.5 OTHERS
13 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY
13.1 OVERVIEW
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 EUROFINS SCIENTIFIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 LABCORP DRUG DEVELOPMENT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 SERVICE PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CHARLES RIVER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 SERVICE PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 WUXI APPTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SERVICE PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 EVOTEC SE
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 SERVICE PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 THERMO FISHER SCIENTIFIC INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 SERVICE PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.6.4.1 ACQUISITION
16.7 AURIGENE PHARMACEUTICAL SERVICES (A SUBSIDIARY OF DR. REDDY'S LABORATORIES)
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 BIOBLOCKS INC
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 CERTARA INC
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 SERVICE PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 DRUG DISCOVERY ALLIANCES
16.10.1 COMPANY SNAPSHOT
16.10.2 SERVICE PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 GENSCRIPT BIOTECH
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 SERVICE PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 JUBILANT BIOSYS
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 NANOSYN
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 NEREID THERAPEUTICS
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PFIZER INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 SELVITA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 SERVICE PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.16.4.1 ACQUISITION
16.17 SPECTRIS PLC
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 SYGNATURE DISCOVERY
16.18.1 COMPANY SNAPSHOT
16.18.2 SERVICE PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 7 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 8 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN 2020-2029 (USD MILLION)
TABLE 9 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 10 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 11 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 12 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 13 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 14 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 15 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 16 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 18 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 19 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 20 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 21 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
Lista de figuras
FIGURE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DROC ANALYSIS
FIGURE 4 MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 11 GROWTH IN BIOLOGICS DISCOVERY AND COLLABORATION AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PROCESS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
FIGURE 14 ESTIMATED NEW CANCER CASES IN 2021, IN THE U.S.
FIGURE 15 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2021
FIGURE 16 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2020-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, LIFELINE CURVE
FIGURE 19 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2021
FIGURE 20 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 23 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2021
FIGURE 24 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2020-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2021
FIGURE 28 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, LIFELINE CURVE
FIGURE 31 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2021
FIGURE 32 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SNAPSHOT (2021)
FIGURE 36 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021)
FIGURE 37 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS (2022-2029)
FIGURE 40 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY SHARE 2021 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
